These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 215844)
1. Epstein-Barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer. Halili MR; Spigland I; Foster N; Ghossein NA J Surg Oncol; 1978; 10(5):457-63. PubMed ID: 215844 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus antibody titers in cancer of the head and neck. Callaghan DJ; Conner BR; Strauss M Arch Otolaryngol; 1983 Dec; 109(12):781-4. PubMed ID: 6314955 [TBL] [Abstract][Full Text] [Related]
3. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948 [TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282 [TBL] [Abstract][Full Text] [Related]
5. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia. Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785 [TBL] [Abstract][Full Text] [Related]
6. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC). Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck. Ringborg U; Henle W; Henle G; Ingimarsson S; Klein G; Silfversward C; Strander H Cancer; 1983 Oct; 52(7):1237-43. PubMed ID: 6309355 [TBL] [Abstract][Full Text] [Related]
9. An immunologic basis for detection of occult primary malignancies of the head and neck. Coates HL; Pearson GR; Neel HB; Weiland LH; Devine KD Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Henle G; Henle W Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions. Lindemalm C; Biberfeld P; Björkholm M; Henle G; Henle W; Holm G; Johansson B; Klein G; Mellstedt H Int J Cancer; 1983 Dec; 32(6):675-82. PubMed ID: 6317577 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Liu MT; Yeh CY Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898 [TBL] [Abstract][Full Text] [Related]
14. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus antibodies in patients with carcinoma of the nasopharynx and carcinoma of other sites in the head and neck. Sako K; Minowada J; Marchetta FC Am J Surg; 1975 Oct; 130(4):437-9. PubMed ID: 170838 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr capsid antigen. Henle W; Henie G J Natl Cancer Inst; 1977 Mar; 58(3):785-6. PubMed ID: 190417 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus antibodies in Sudanese patients with nasopharyngeal carcinoma: a preliminary report. Malik MO; Banatvala J; Hutt MS; Abu-Sin AY; Hidaytallah A; El-Hadi AE J Natl Cancer Inst; 1979 Feb; 62(2):221-4. PubMed ID: 216831 [TBL] [Abstract][Full Text] [Related]
18. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma. Kottaridis SD; Goula I; Kiparissiadis P Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911 [No Abstract] [Full Text] [Related]
20. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]